Peter Marbach

6.4k total citations · 1 hit paper
112 papers, 4.9k citations indexed

About

Peter Marbach is a scholar working on Computer Networks and Communications, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Peter Marbach has authored 112 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Computer Networks and Communications, 32 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Epidemiology. Recurrent topics in Peter Marbach's work include Neuroendocrine Tumor Research Advances (24 papers), Growth Hormone and Insulin-like Growth Factors (22 papers) and Advanced Wireless Network Optimization (19 papers). Peter Marbach is often cited by papers focused on Neuroendocrine Tumor Research Advances (24 papers), Growth Hormone and Insulin-like Growth Factors (22 papers) and Advanced Wireless Network Optimization (19 papers). Peter Marbach collaborates with scholars based in Canada, Switzerland and United States. Peter Marbach's co-authors include U. Briner, John N. Tsitsiklis, Janos Pless, W. Doepfner, W. Bauer, Trevor J. Petcher, R Huguenin, Ying Qiu, Ioana Lancranjan and Randall Berry and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, IEEE Transactions on Automatic Control and Brain Research.

In The Last Decade

Peter Marbach

110 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1982 1.1k citations W. Bauer, U. Briner et al. Life Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Marbach Canada	34	1.5k	1.2k	961	873	791	112	4.9k
Xiaoyun Zhu China	48	351 0.2×	204 0.2×	3.0k 3.1×	1.2k 1.4×	2.0k 2.5×	221	8.0k
Xavier Leroy France	45	341 0.2×	278 0.2×	437 0.5×	681 0.8×	2.1k 2.7×	297	8.4k
Hiroshi Maruyama Japan	29	327 0.2×	736 0.6×	125 0.1×	548 0.6×	753 1.0×	239	3.3k
Steven Swanson United States	65	204 0.1×	119 0.1×	5.1k 5.3×	1.4k 1.6×	476 0.6×	323	14.4k
Javed Khan United States	51	399 0.3×	109 0.1×	216 0.2×	2.2k 2.5×	6.2k 7.9×	350	10.9k
Junichi Suzuki Japan	25	99 0.1×	291 0.2×	508 0.5×	134 0.2×	608 0.8×	284	3.1k
Takafumi Yoshida Japan	35	898 0.6×	412 0.3×	47 0.0×	1.3k 1.5×	1.1k 1.4×	130	5.1k
Ahmed Sultan Egypt	29	204 0.1×	107 0.1×	550 0.6×	765 0.9×	466 0.6×	188	2.9k
George Riley United States	23	419 0.3×	57 0.0×	1.0k 1.1×	272 0.3×	2.7k 3.5×	72	5.4k
Douglas T. Ross United States	39	679 0.5×	175 0.1×	167 0.2×	7.4k 8.5×	11.5k 14.5×	103	21.3k

Countries citing papers authored by Peter Marbach

Since Specialization

Citations

This map shows the geographic impact of Peter Marbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Marbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Marbach more than expected).

Fields of papers citing papers by Peter Marbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Marbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Marbach. The network helps show where Peter Marbach may publish in the future.

Co-authorship network of co-authors of Peter Marbach

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Marbach. A scholar is included among the top collaborators of Peter Marbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Marbach. Peter Marbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ioannidis, Stratis & Peter Marbach. (2009). Absence of Evidence as Evidence of Absence: A Simple Mechanism for Scalable P2P Search. 576–584. 11 indexed citations

Eryılmaz, Atilla, Peter Marbach, & Asuman Ozdaglar. (2008). A fluid-flow model for backlog-based CSMA policies. 77. 4 indexed citations

Haschke, Manuel, et al.. (2007). Crossreactivity of Isolated Everolimus Metabolites With the Innofluor Certican Immunoassay for Therapeutic Drug Monitoring of Everolimus. Therapeutic Drug Monitoring. 29(6). 743–749. 22 indexed citations

Roberts, Mark, et al.. (2005). A New FPIA Immunoassay for the Quantitative Determination of Everolimus in Whole Blood. Therapeutic Drug Monitoring. 27(2). 213–214. 5 indexed citations

Marbach, Peter, et al.. (2004). End-to-end rate control for networks with random access links. 2437–2440. 1 indexed citations

Qiu, Ying & Peter Marbach. (2003). Bandwidth Allocation in Wireless Ad Hoc Networks: A Price-Based Approach.. 797–807. 35 indexed citations

Dimaraki, Eleni V., Craig A. Jaffe, Cyril Y. Bowers, Peter Marbach, & Ariel L. Barkan. (2003). Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin. American Journal of Physiology-Endocrinology and Metabolism. 285(1). E163–E170. 23 indexed citations

Marbach, Peter, et al.. (2003). Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1085–1092. 225 indexed citations

Ørskov, Hans, et al.. (2000). Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment. European Journal of Endocrinology. 143(3). 353–361. 10 indexed citations

10.

Thanou, Maya, J. Coos Verhoef, Peter Marbach, & Hans E. Junginger. (2000). Intestinal Absorption of Octreotide: N‐Trimethyl Chitosan Chloride (TMC) Ameliorates the Permeability and Absorption Properties of the Somatostatin Analogue In Vitro and In Vivo. Journal of Pharmaceutical Sciences. 89(7). 951–957. 107 indexed citations

11.

Comets, Emmanuelle, France Mentré, Ryosei Kawai, et al.. (2000). Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits. Journal of Pharmaceutical Sciences. 89(9). 1123–1133. 13 indexed citations

12.

Marbach, Peter, et al.. (1997). Reinforcement Learning for Call Admission Control and Routing in Integrated Service Networks. Neural Information Processing Systems. 10. 922–928. 18 indexed citations

13.

Lancranjan, Ioana, Christian Bruns, P. Graß, et al.. (1996). Sandostatin® LAR®: A promising therapeutic tool in the management of acromegalic patients. Metabolism. 45(8 Suppl 1). 67–71. 119 indexed citations

14.

Lancranjan, Ioana, Christian Bruns, P. Graß, et al.. (1995). Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients. Metabolism. 44. 18–26. 73 indexed citations

15.

Marbach, Peter, U. Briner, Michel Lemaire, A. Schweitzer, & Tetsuya Terasaki. (1993). From Somatostatin to Sandostatin®: Pharmacodynamics and Pharmacokinetics. Digestion. 54(1). 9–13. 17 indexed citations

16.

Marbach, Peter, et al.. (1993). A time-resolved fluoroimmunoassay for human insulin based on two monoclonal antibodies. Journal of Immunological Methods. 157(1-2). 197–201. 7 indexed citations

17.

Dullaart, Robin P. F., S. Meijer, Peter Marbach, & Wim J. Sluiter. (1992). Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients. European Journal of Clinical Investigation. 22(7). 494–502. 27 indexed citations

18.

Bakker, Willem H., E. P. Krenning, J.C. Reubi, et al.. (1991). In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sciences. 49(22). 1593–1601. 141 indexed citations

19.

Lemaire, Michel, et al.. (1989). Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.. Drug Metabolism and Disposition. 17(6). 699–703. 47 indexed citations

20.

Marbach, Peter, et al.. (1988). Structure-Function Relationships of Somatostatin Analogs. Hormone Research. 29(2-3). 54–58. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact